BRCA: Difference between revisions
No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 12: | Line 12: | ||
== Structural highlights == | == Structural highlights == | ||
The <scene name='75/750267/Cv/5'>phosphopeptide binds at the interface between the BRCT1 and BRCT2 domains</scene>. These domains contain most of the mutations seen in BRCA1<ref>PMID:18452305</ref>. <scene name='75/750267/Cv/6'>Phosphoserine binding</scene>. | The <scene name='75/750267/Cv/5'>phosphopeptide binds at the interface between the BRCT1 and BRCT2 domains</scene>. These domains contain most of the mutations seen in BRCA1<ref>PMID:18452305</ref>. <scene name='75/750267/Cv/6'>Phosphoserine binding</scene>. | ||
==3D structures of BRCA== | |||
[[BRCA 3D structures]] | |||
</StructureSection> | </StructureSection> | ||